The RAASi Debate: Should RAAS Blockade Continue With a Declining eGFR?
Heart Failure 2015, Seville, Spain
Monday, May 25, 2015
During this live educational program moderated by Dr. Marisa Crespo-Leiro, highly regarded clinicians in the space of cardiology and nephrology will debate on the argument of RAAS inhibition and should therapy continue in HF/CKD patients with a rise in creatinine/decline in eGFR. Both teams include a premier expert in heart failure and an esteemed expert in nephrology.